Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination Administered in Patients Infected With Chronic Genotype 1 or 4 HCV for Use in the Peri-Operative Liver Transplantation Setting
Clinical trial NCT02350569 · COMPLETED
Trial details
- NCT number
- NCT02350569
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-22
- Primary completion
- 2016-03-28
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.